Report overview
The global Viral Vector and Vaccine market was valued at US$ million in 2023 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2023, While China is Forecast to Reach $ Million.
Adenovirus Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Viral Vector and Vaccine include ABL, Addgene, Aldevron, Boehringer Ingelheim International GmbH, Brammer Bio, Charles River Laboratories, Creative-Biogene, Fujifilm Corporation and General Electric, etc. in 2023, the global top five players have a share approximately % in terms of revenue.
This report aims to provide a comprehensive presentation of the global market for Viral Vector and Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Viral Vector and Vaccine. This report contains market size and forecasts of Viral Vector and Vaccine in global, including the following market information:
Global Viral Vector and Vaccine Market Revenue, 2019-2024, 2025-2030, ($ millions)
Global Viral Vector and Vaccine Market Sales, 2019-2024, 2025-2030, (K Units)
Global top five Viral Vector and Vaccine companies in 2023 (%)
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Viral Vector and Vaccine manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Viral Vector and Vaccine Market, by Type, 2019-2024, 2025-2030 ($ Millions) & (K Units)
Global Viral Vector and Vaccine Market Segment Percentages, by Type, 2023 (%)
Adenovirus
Fowlpox Virus
Attenuated Yellow Fever
Vaccinia Virus Vectors
Global Viral Vector and Vaccine Market, by Application, 2019-2024, 2025-2030 ($ Millions) & (K Units)
Global Viral Vector and Vaccine Market Segment Percentages, by Application, 2023 (%)
Research Institutes
Biopharmaceutical Companies
Others
Global Viral Vector and Vaccine Market, By Region and Country, 2019-2024, 2025-2030 ($ Millions) & (K Units)
Global Viral Vector and Vaccine Market Segment Percentages, By Region and Country, 2023 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Viral Vector and Vaccine revenues in global market, 2019-2024 (Estimated), ($ millions)
Key companies Viral Vector and Vaccine revenues share in global market, 2023 (%)
Key companies Viral Vector and Vaccine sales in global market, 2019-2024 (Estimated), (K Units)
Key companies Viral Vector and Vaccine sales share in global market, 2023 (%)
Further, the report presents profiles of competitors in the market, key players include:
ABL
Addgene
Aldevron
Boehringer Ingelheim International GmbH
Brammer Bio
Charles River Laboratories
Creative-Biogene
Fujifilm Corporation
General Electric
MerckKGaA
Novasep
Pfizer
Spark Therapeutics
Thermo Fisher Scientific
Waisman Biomanufacturing
Outline of Major Chapters:
Chapter 1: Introduces the definition of Viral Vector and Vaccine, market overview.
Chapter 2: Global Viral Vector and Vaccine market size in revenue and volume.
Chapter 3: Detailed analysis of Viral Vector and Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Viral Vector and Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Viral Vector and Vaccine capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
